Skip to main content

Table 2 The 35 discriminating m/z peaks between patients with TB and non-TB control subjects

From: The discovery and identification of a candidate proteomic biomarker of active tuberculosis

m/z

P a

Fold

m/z

P a

Fold

m/z

P a

Fold

4824.4b

0

+6.8

1819.4

1.0 × 10-6

+1.5

5199.8

1.3 × 10-4

-2.4

6924.9

1.0 × 10-10

-1.7

1934.0

2.1 × 10-6

+1.6

6075.4

3.0 × 10-4

-1.5

2513.0

1.0 × 10-10

+1.6

16015.9

4.7 × 10-6

-1.5

5733.5

4.6 × 10-4

-1.7

1662.4

2.0 × 10-10

+1.5

1687.1

1.3 × 10-5

+2.7

1600.3

8.5 × 10-4

+7.5

2958.0

9.7 × 10-9

+1.8

7752.3

2.1 × 10-5

-2.0

2603.8

0.001

+2.3

4537.9

1.4 × 10-8

+1.6

1575.5

2.2 × 10-5

+1.6

5896.9

0.002

-1.8

6098.2

3.5 × 10-8

-1.6

1596.3

2.3 × 10-5

+1.5

2012.2

0.003

-2.4

2554.6b

4.1 × 10-8

+5.8

10263.8

4.2 × 10-5

+2.4

3242.4

0.003

-1.6

2310.2

9.3 × 10-8

+1.5

8606.8b

4.5 × 10-5

+1.9

1799.3

0.008

+1.6

3959.5

4.0 × 10-7

-1.9

5129.8

5.7 × 10-5

-2.1

2010.3

0.008

-4.3

15855.9

4.4 × 10-7

-1.6

1615.6

6.2 × 10-5

+1.7

2339.5

0.009

+2.9

9269.9

6.3 × 10-7

-1.9

5325.7b

1.0 × 10-4

-2.6

N/A

N/A

N/A

  1. m/z means mass-to-charge ratio. a Generated by peak comparison between TB and non-TB controls. b Peak selected as biomarkers for TB diagnostic model. +fold change (up-regulated), - fold change (down-regulated).
  2. P < 10-10 regarded as 0.